Skip to main content

UBS Group AG

Position in ANTX — AN2 Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ANTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$358,576
+$148,617 QoQ
Shares Held
74,086
+20.7% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 66 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. ANTX ranks #312 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $358,576 74,086
2026-03-31 $209,959 61,392
2025-12-31 $64,601 56,668
2025-09-30 $72,000 56,694
2025-06-30 $65,720 62,000
2025-03-31 $144,188 106,021
2024-12-31 $235,002 170,292
2024-06-30 $37,588 17,483
2024-03-31 $63,615 19,574
2023-09-30 $660,019 41,046
2023-06-30 $422,220 49,673
2023-03-31 $515,460 52,225
2022-12-31 $490,366 51,455
2022-09-30 $505,879 29,107
2022-06-30 $374,843 48,367
2022-03-31 $17,450 1,158